🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Anti-HER2 therapy, such as trastuzumab and pertuzumab, has significantly im...
Status
Active Not Recruiting
Location
Natera
Start Date
2024-04-01
Trial ID
NCT06663787
Treatments Being Tested
The purpose of this study is to identify patients who may be eligible to pa...
Status
Completed
Location
Miami Cancer Institute
Start Date
2021-12-14
Trial ID
NCT05158621
The purpose of this study is to investigate the use of ctDNA measurements t...
Status
Recruiting
Location
NYU Langone Health
Start Date
2026-04-13
Trial ID
NCT07504796
Treatments Being Tested
This study is a single-center, prospective, observational clinical trial en...
Status
Recruiting
Location
Beijing Friendship Hospital
Start Date
2026-02-15
Trial ID
NCT07393048
Treatments Being Tested
Ovarian cancer ranks third in the incidence of gynecologic malignancies, wh...
Status
Unknown
Location
west china second University， SICHUAN University, China
Start Date
2023-10-01
Trial ID
NCT06182917
Breast cancer seriously threatens the health of women worldwide. The HER-2-...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-08-25
Trial ID
NCT07132502
Treatments Being Tested
Establish the clinical technology system of routine adjuvant therapy combin...
Status
Enrolling By Invitation
Location
No 1111 Wenzhou Avenue (East Section), Longwan District, Wenzhou City, Zhejiang Province, China
Start Date
2024-07-01
Trial ID
NCT06434376